^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    orvacabtagene autoleucel (JCARH125)

    i
    Other names: JCARH125, anti-BCMA CAR-T cell therapy, JCARH-125, BCMA targeted CAR-T cell
    Associations
    News
    Trials
    Company:
    BMS
    Drug class:
    BCMA-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials